Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Solid Tumor Cancer 2Breast Neoplasms 2Solid Tumours 1Recurrence 1Ovarian Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

ispinesib 2trifluridine tipiracil drug combination 1tipiracil 1Trifluridine 1SB 743921 1Interleukin-18 1Docetaxel 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Solid Tumor Cancer × ispinesib × Clear all
NCT00119171 2008-10-16

Ispinesib In Combination With Capecitabine In Patients With Solid Tumors

GlaxoSmithKline

Phase 1 Completed
30 enrolled
Other solid neoplasm

Solid Tumor Cancer

NCT00169520 2008-10-16

SB-715992 In Combination With Docetaxel In Patients With Solid Tumors

GlaxoSmithKline

Phase 1 Completed
30 enrolled
Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡